Coral Drugs Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 18-07-2024
- Paid Up Capital ₹ 5.10 M
as on 18-07-2024
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.35 Cr
as on 18-07-2024
- Satisfied Charges ₹ 38.05 Cr
as on 18-07-2024
- Revenue 22.16%
(FY 2023)
- Profit 23.00%
(FY 2023)
- Ebitda 25.73%
(FY 2023)
- Net Worth 14.12%
(FY 2023)
- Total Assets 11.60%
(FY 2023)
About Coral Drugs
The Corporate was formerly known as Coral Tex Knit Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 5.10 M.
The company currently has active open charges totaling ₹11.35 Cr. The company has closed loans amounting to ₹38.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Binay Bhuwania, Rohit Bhuwania, Meena Bhuwania, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74899DL1993PTC056582
- Company No.
056582
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 1993
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Coral Drugs Private Limited offer?
Coral Drugs Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Testing & Measuring Equipments, Test Kits, Organic and Inorganic Solvents, Ketones, Pharmaceutical Medicine, Sexual Wellness Products, Contraceptives, TB, Tumor & Cancer Drugs.
Who are the key members and board of directors at Coral Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Bhuwania  | Managing Director | 07-Nov-2002 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meena Bhuwania | Whole-Time Director | 01-Dec-1998 | Current |
| Binay Bhuwania | Whole-Time Director | 22-Dec-1993 | Current |
| Pawan Agarwal | Additional Director | 22-Feb-2024 | Current |
| Ravi Srivastava | Whole-Time Director | 20-Sep-2023 | Current |
Financial Performance and Corporate Structure Insights of Coral Drugs.
Coral Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.16% increase. The company also saw a substantial improvement in profitability, with a 23% increase in profit. The company's net worth Soared by an impressive increase of 14.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Coral Drugs?
In 2023, Coral Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Coral Chemicals Private LimitedActive 41 years 1 monthBinay Bhuwania, Rohit Bhuwania and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Feb 2021 | ₹7.00 Cr | Open |
Others Creation Date: 29 Nov 2017 | ₹5.21 M | Open |
Bank Of India Creation Date: 01 Sep 2017 | ₹3.23 Cr | Open |
How Many Employees Work at Coral Drugs?
Unlock and access historical data on people associated with Coral Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Coral Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coral Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
